BNTX vs ROIV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BNTX · BioNTech$80.96 ▼ 0.52%
ROIV · Roivant Sciences$38.66 ▼ 0.78%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BNTX -16.1%
- ROIV +90.4%
Head to head
| Metric | BNTX | ROIV |
|---|---|---|
| Price | $80.96 | $38.66 |
| Change today | ▼ 0.52% | ▼ 0.78% |
| Market cap | $20.07B | $28.01B |
| Return, 3 months | -28.2% | +6.3% |
| Return, year to date | -15.0% | +78.1% |
| Return, 1 year | -15.3% | +91.2% |
| P/E (TTM) | – | – |
| P/B | 1.0 | 7.0 |
| P/E percentile vs own 5y | 44th | 6th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -15.1% | +2,135.6% |
| Net profit growth (YoY) | +742.9% | +17.4% |
| Gross margin | 75.0% | 88.7% |
| Operating margin | -72.7% | -3,234.0% |
| Net margin | -60.9% | -838.2% |
| Return on equity | -8.1% | -8.2% |
| Analyst target vs. price | +47.4% | +26.5% |
| Analyst buy share | 75% | 82% |
| RSI (14) | 31 | 53 |
| 30-day volatility | 35.9% | 44.7% |
| Max drawdown, 1 year | -32.2% | -20.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ROIV is the largest of the group by market value.
- ROIV has returned the most over the past year.
- ROIV is growing revenue fastest.
- BNTX keeps the most profit per dollar of sales.
- BNTX has been the calmest stock over the last 30 days.